Broadcom stock falls despite new AI data center partnership

Shares of Broadcom AVGO fell sharply on Tuesday as investors continued to rotate away from high-growth technology stocks. The decline came despite the company’s announcement of a major artificial intelligence infrastructure partnership with Apollo Global Management and Blackstone. Broadcom stock dropped 6.2% during the session as the broader technology sector remained under pressure. The stock… Continue reading Broadcom stock falls despite new AI data center partnership

Veeco stock soars on NSA500 order as chip demand gains momentum

Shares of Veeco Instruments VECO moved sharply higher on Tuesday after the semiconductor equipment maker announced a follow-on order for its Nanosecond Annealing System (NSA500). The move signals growing customer confidence in the company’s technology for advanced chip manufacturing. The stock gained as much as 19% during the session, extending its recent rally. At the… Continue reading Veeco stock soars on NSA500 order as chip demand gains momentum

Apple stock falls 4% after AI reveal despite analyst optimism on Siri

Apple AAPL shares fell 4.4% on Tuesday, a day after the company unveiled a series of artificial intelligence initiatives at its annual Worldwide Developers Conference (WWDC). The decline put the stock on track for its worst daily performance since February. The move came despite largely positive reactions from analysts to Apple’s latest AI announcements, including… Continue reading Apple stock falls 4% after AI reveal despite analyst optimism on Siri

Why Tesla stock is crashing around 5% today

Tesla stock (TSLA) plunged around 5% on Tuesday, giving back much of the previous session’s gains as a broader selloff in technology and semiconductor stocks weighed heavily on investor sentiment. The electric-vehicle maker’s stock had surged roughly 4.5% on Monday but reversed sharply as risk appetite faded across the market. US equities broadly declined on… Continue reading Why Tesla stock is crashing around 5% today

Jensen Huang strikes again, recommends buying Qualcomm stock

Nvidia chief executive Jensen Huang brought Qualcomm (QCOM) in focus late Monday, issuing an explicit public endorsement of the rival chipmaker. Speaking to tech executives and reporters during his highly anticipated press tour in Seoul, Huang praised QCOM’s dominance in mobile hardware before playfully instructing the audience to “buy their stock” The unscripted remarks caught… Continue reading Jensen Huang strikes again, recommends buying Qualcomm stock

Micron stock falls on Tuesday: Why analysts still see gains ahead

Micron MU shares fell 1.7% on Tuesday, reversing a small portion of its 10% gains on Monday. The decline came after a volatile period for semiconductor stocks, with Micron shares having fallen about 20% over two trading days last week, including a 13% plunge on Friday. Despite the recent pullback, Wall Street analysts remain overwhelmingly… Continue reading Micron stock falls on Tuesday: Why analysts still see gains ahead

Nvidia stock is back in the red today: what’s hurting the AI darling?

Nvidia (NVDA) stock reversed early gains and traded lower on Tuesday, despite Apple confirming that some of its artificial intelligence services will run on Nvidia hardware as part of the iPhone maker’s broader AI strategy. Shares of Nvidia fell 1.3% to $206.13 in early trading. The decline came as broader markets weakened following a sharp… Continue reading Nvidia stock is back in the red today: what’s hurting the AI darling?

Dow futures climb 125 points: 5 things to know before Wall Street opens

US stock-index futures advanced on Tuesday as chipmakers extended their rebound and easing tensions in the Middle East helped restore some appetite for risk. Futures tied to the S&P 500 rose about 0.39%, while Nasdaq 100 futures gained 0.67%. Futures linked to the Dow Jones Industrial Average advanced over 125 points, or 0.25%. The move… Continue reading Dow futures climb 125 points: 5 things to know before Wall Street opens

GSK’s $10.6B Nuvalent takeover fails to impress investors as shares fall: here’s why

GlaxoSmithKline is making its largest oncology acquisition in years with a $10.6 billion deal for US-based cancer drug developer Nuvalent, betting that a trio of promising lung cancer therapies can help drive future growth and offset looming patent expirations in its HIV portfolio. The acquisition, announced on Tuesday, will give the British pharmaceutical giant access… Continue reading GSK’s $10.6B Nuvalent takeover fails to impress investors as shares fall: here’s why